GovWire

Decision: Regulatory approval of Spikevax (formerly COVID-19 Vaccine Moderna)

Medicines Healthcare Products Regulatory Agency

May 9
13:06 2023

Last updated 9/5/23 - Summary of Product Characteristics for Spikevax 0.1 mg/mL dispersion for injection

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Last updated 2/3/23 - Summary of Product Characteristics for Spikevax 0.2 mg/mL multidose vial

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Last updated 2/3/23 - Patient Information Leaflet (PIL) for Spikevax 0.2 mg/mL multidose vial

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: